Argos Therapeutics Inc (NASDAQ:ARGS)

9.08
Delayed Data
As of 3:59pm ET
 +0.04 / +0.44%
Today’s Change
5.61
Today|||52-Week Range
13.74
-9.20%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close9.04
Today’s open8.98
Day’s range8.85 - 9.24
Volume29,790
Average volume (3 months)57,269
Market cap$177.7M
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-436.28%
Earnings growth (this year)+98.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.18%
P/E ratio--
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...-0.04-1.63%
MSLIMerus Labs Internati...-0.04-1.84%
NHTCNatural Health Trend...+0.02+0.15%
AKBAAkebia Therapeutics ...+0.40+4.41%
Data as of 4:00pm ET, 03/03/2015

Financials

Next reporting dateMarch 27, 2015
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$4.4M
Annual profit (last year)-$23.9M
Net profit margin-541.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account